172 related articles for article (PubMed ID: 22526675)
1. Enterohemorrhagic Escherichia coli O157:H7 Shiga toxins inhibit gamma interferon-mediated cellular activation.
Ho NK; Ossa JC; Silphaduang U; Johnson R; Johnson-Henry KC; Sherman PM
Infect Immun; 2012 Jul; 80(7):2307-15. PubMed ID: 22526675
[TBL] [Abstract][Full Text] [Related]
2. Identifying mechanisms by which Escherichia coli O157:H7 subverts interferon-γ mediated signal transducer and activator of transcription-1 activation.
Ho NK; Crandall I; Sherman PM
PLoS One; 2012; 7(1):e30145. PubMed ID: 22253910
[TBL] [Abstract][Full Text] [Related]
3. Enterohemorrhagic Escherichia coli O157:H7 disrupts Stat1-mediated gamma interferon signal transduction in epithelial cells.
Ceponis PJ; McKay DM; Ching JC; Pereira P; Sherman PM
Infect Immun; 2003 Mar; 71(3):1396-404. PubMed ID: 12595457
[TBL] [Abstract][Full Text] [Related]
4. Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1.
Jandu N; Zeng ZJ; Johnson-Henry KC; Sherman PM
Microbiology (Reading); 2009 Feb; 155(Pt 2):531-540. PubMed ID: 19202101
[TBL] [Abstract][Full Text] [Related]
5. Conditioned medium from enterohemorrhagic Escherichia coli-infected T84 cells inhibits signal transducer and activator of transcription 1 activation by gamma interferon.
Jandu N; Ceponis PJ; Kato S; Riff JD; McKay DM; Sherman PM
Infect Immun; 2006 Mar; 74(3):1809-18. PubMed ID: 16495555
[TBL] [Abstract][Full Text] [Related]
6. Multiple seropathotypes of verotoxin-producing Escherichia coli (VTEC) disrupt interferon-gamma-induced tyrosine phosphorylation of signal transducer and activator of transcription (Stat)-1.
Jandu N; Shen S; Wickham ME; Prajapati R; Finlay BB; Karmali MA; Sherman PM
Microb Pathog; 2007; 42(2-3):62-71. PubMed ID: 17174521
[TBL] [Abstract][Full Text] [Related]
7. Role of Shiga Toxins in Cytotoxicity and Immunomodulatory Effects of
Bruballa AC; Shiromizu CM; Bernal AM; Pineda GE; Sabbione F; Trevani AS; Bentancor LV; Ramos MV; Fernández-Brando RJ; Muñoz MJ; Palermo MS
Toxins (Basel); 2020 Jan; 12(1):. PubMed ID: 31947665
[TBL] [Abstract][Full Text] [Related]
8. Enterohemorrhagic Escherichia coli O157:H7 gene expression profiling in response to growth in the presence of host epithelia.
Jandu N; Ho NK; Donato KA; Karmali MA; Mascarenhas M; Duffy SP; Tailor C; Sherman PM
PLoS One; 2009; 4(3):e4889. PubMed ID: 19293938
[TBL] [Abstract][Full Text] [Related]
9. [Construction and immunization of a enterohemorrhagic Escherichia coli O157 attenuated].
Liu J; Sun Y; Feng SZ
Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):211-7. PubMed ID: 17460890
[TBL] [Abstract][Full Text] [Related]
10. Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins.
Liu J; Sun Y; Feng S; Zhu L; Guo X; Qi C
Vaccine; 2009 Oct; 27(43):5929-35. PubMed ID: 19682616
[TBL] [Abstract][Full Text] [Related]
11. Virulence genes of Shiga toxin-producing Escherichia coli isolated from food, animals and humans.
Meng J; Zhao S; Doyle MP
Int J Food Microbiol; 1998 Dec; 45(3):229-35. PubMed ID: 9927001
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli.
Kehl KS; Havens P; Behnke CE; Acheson DW
J Clin Microbiol; 1997 Aug; 35(8):2051-4. PubMed ID: 9230380
[TBL] [Abstract][Full Text] [Related]
13. Designing of a chimeric protein contains StxB, intimin and EscC against toxicity and adherence of enterohemorrhagic Escherichia coli O157:H7 and evaluation of serum antibody titers against it.
Sadri Najafabadi Z; Nazarian S; Kargar M; Kafilzadeh F
Mol Immunol; 2021 Jun; 134():218-227. PubMed ID: 33823320
[TBL] [Abstract][Full Text] [Related]
14. Intestinal adherence associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7.
Xicohtencatl-Cortes J; Monteiro-Neto V; Ledesma MA; Jordan DM; Francetic O; Kaper JB; Puente JL; Girón JA
J Clin Invest; 2007 Nov; 117(11):3519-29. PubMed ID: 17948128
[TBL] [Abstract][Full Text] [Related]
15. Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8.
Berin MC; Darfeuille-Michaud A; Egan LJ; Miyamoto Y; Kagnoff MF
Cell Microbiol; 2002 Oct; 4(10):635-48. PubMed ID: 12366401
[TBL] [Abstract][Full Text] [Related]
16. Adherent-invasive Escherichia coli blocks interferon-γ-induced signal transducer and activator of transcription (STAT)-1 in human intestinal epithelial cells.
Ossa JC; Ho NK; Wine E; Leung N; Gray-Owen SD; Sherman PM
Cell Microbiol; 2013 Mar; 15(3):446-57. PubMed ID: 23072252
[TBL] [Abstract][Full Text] [Related]
17. Exocytotic secretion of toxins from macrophages infected with Escherichia coli O157.
Shimada O; Ishikawa H; Tosaka-Shimada H; Atsumi S
Cell Struct Funct; 1999 Oct; 24(5):247-53. PubMed ID: 15216879
[TBL] [Abstract][Full Text] [Related]
18. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
[TBL] [Abstract][Full Text] [Related]
19. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
[TBL] [Abstract][Full Text] [Related]
20. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
